Li Yang Hsu
Impact in
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 44
-
- Antibiotic Resistance in Bacteria 50
- Co-authors
- Thean Yen TanHelena Legido‐QuigleyAlex R. CookYik Ying TeoAnucha ApisarnthanarakTse Hsien KohPaul Anantharajah TambyahJames L. Hedrick
- Journals
- Antimicrobial Agents and Chemotherapy (9 papers)Antibiotics (6 papers)PLoS ONE (6 papers)Scientific Reports (5 papers)Clinical Microbiology and Infection (5 papers)
- Partner nations
- SingaporeUnited KingdomUnited States
In The Last Decade
Li Yang Hsu
197 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 192
- Applied Microbiology and Biotechnology 1.1k
- Molecular Medicine 2.0k
- Infectious Diseases 2.6k
- Clinical Biochemistry 886
- Modeling and Simulation 584
Countries citing papers authored by Li Yang Hsu
This map shows the geographic impact of Li Yang Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yang Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yang Hsu more than expected).
Fields of papers citing papers by Li Yang Hsu
This network shows the impact of papers produced by Li Yang Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yang Hsu. The network helps show where Li Yang Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Yang Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 72 | |
| 13 | 2020 | 27 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 353 | |
| 16 | 2020 | 9 | |
| 17 | 2016 | 253 | |
| 18 | 2014 | 15 | |
| 19 | Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. | 2012 | 18 |
| 20 | 2010 | 2 |
About Li Yang Hsu
Li Yang Hsu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Modeling and Simulation, having authored 199 papers that have together received 8.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (50 papers), Antibiotic Use and Resistance (44 papers), Bacterial Identification and Susceptibility Testing (39 papers), Antimicrobial Resistance in Staphylococcus (36 papers), COVID-19 epidemiological studies (18 papers), Tuberculosis Research and Epidemiology (17 papers), Pneumonia and Respiratory Infections (17 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.1k citations), Molecular Medicine (2.0k citations), Infectious Diseases (2.6k citations), Clinical Biochemistry (886 citations) and Modeling and Simulation (584 citations). Li Yang Hsu has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Thean Yen Tan, Helena Legido‐Quigley, Alex R. Cook, Yik Ying Teo, Anucha Apisarnthanarak, Tse Hsien Koh, Paul Anantharajah Tambyah, James L. Hedrick, Chuan Yang and Andrea Lay‐Hoon Kwa. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antibiotics, PLoS ONE, Scientific Reports and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.